BE438175A - - Google Patents
Info
- Publication number
- BE438175A BE438175A BE438175DA BE438175A BE 438175 A BE438175 A BE 438175A BE 438175D A BE438175D A BE 438175DA BE 438175 A BE438175 A BE 438175A
- Authority
- BE
- Belgium
- Prior art keywords
- materials
- hormone
- hormones
- compounds
- brought
- Prior art date
Links
- 229940088597 hormone Drugs 0.000 claims description 26
- 239000005556 hormone Substances 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 22
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 8
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 6
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 102000035195 Peptidases Human genes 0.000 claims description 5
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 claims description 5
- 241000157855 Cinchona Species 0.000 claims description 4
- 210000004907 gland Anatomy 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 235000021513 Cinchona Nutrition 0.000 claims description 3
- 229930013930 alkaloid Natural products 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 3
- 238000004040 coloring Methods 0.000 claims description 2
- 230000007423 decrease Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 125000002950 monocyclic group Chemical group 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 125000003367 polycyclic group Chemical group 0.000 claims description 2
- 239000011149 active material Substances 0.000 claims 1
- 230000003054 hormonal effect Effects 0.000 claims 1
- 108090000631 Trypsin Proteins 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- -1 euoupine Chemical compound 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000001096 (4-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol hydrochloride Substances 0.000 description 1
- WJJQLITYTBVNRP-UHFFFAOYSA-N (4-oxocyclohexa-2,5-dien-1-ylidene)oxidanium;chloride Chemical compound Cl.O=C1C=CC(=O)C=C1 WJJQLITYTBVNRP-UHFFFAOYSA-N 0.000 description 1
- DIOGDSVVUWNLHM-UHFFFAOYSA-N (5-ethyl-1-azabicyclo[2.2.2]octan-2-yl)-[6-(6-methylheptoxy)quinolin-4-yl]methanol Chemical compound C1=C(OCCCCCC(C)C)C=C2C(C(O)C3CC4CCN3CC4CC)=CC=NC2=C1 DIOGDSVVUWNLHM-UHFFFAOYSA-N 0.000 description 1
- NNKXWRRDHYTHFP-HZQSTTLBSA-N (r)-[(2s,4s,5r)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;hydron;dichloride Chemical compound Cl.Cl.C([C@H]([C@H](C1)C=C)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 NNKXWRRDHYTHFP-HZQSTTLBSA-N 0.000 description 1
- ULBJILHSWMGASA-UHFFFAOYSA-N 1-(2-methoxy-4-nitrophenyl)pyrrolidine Chemical compound COC1=CC([N+]([O-])=O)=CC=C1N1CCCC1 ULBJILHSWMGASA-UHFFFAOYSA-N 0.000 description 1
- UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 description 1
- QMEWZVHQJNALJD-UHFFFAOYSA-N 4-(2,3-dimethylphenyl)pyrazol-3-one Chemical compound CC1=CC=CC(C=2C(N=NC=2)=O)=C1C QMEWZVHQJNALJD-UHFFFAOYSA-N 0.000 description 1
- UOHKZYJHHPCTRP-UHFFFAOYSA-N 4-benzhydrylpyrazol-3-one Chemical compound C1(=CC=CC=C1)C(C1=CC=CC=C1)C=1C(N=NC1)=O UOHKZYJHHPCTRP-UHFFFAOYSA-N 0.000 description 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 108010013369 Enteropeptidase Proteins 0.000 description 1
- 102100029727 Enteropeptidase Human genes 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 1
- KMPWYEUPVWOPIM-KODHJQJWSA-N cinchonidine Chemical compound C1=CC=C2C([C@H]([C@H]3[N@]4CC[C@H]([C@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-KODHJQJWSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- SUWZHLCNFQWNPE-LATRNWQMSA-N optochin Chemical compound C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 SUWZHLCNFQWNPE-LATRNWQMSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 229960003207 papaverine hydrochloride Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229960001404 quinidine Drugs 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 229960001811 quinine hydrochloride Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE438175A true BE438175A (en, 2012) |
Family
ID=96462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE438175D BE438175A (en, 2012) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE438175A (en, 2012) |
-
0
- BE BE438175D patent/BE438175A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0250459B1 (fr) | Compositions desinfectantes et procede de desinfection applicables a des liquides ou des surfaces infectes | |
| EP0037319B2 (fr) | Mucopolysaccharides possédant des propriétés biologiques, leur préparation et leur application en tant que médicaments | |
| EP0078785B1 (fr) | Sels d'acide valproîque, leur préparation et leur utilisation | |
| WO2013087795A1 (fr) | Procede de purification de la vanilline par extraction liquide-liquide | |
| FR2964570A1 (fr) | Procede de preparation d'un extrait de centella asiatica | |
| US7179632B2 (en) | Process for the production of allicin | |
| EP0086315A1 (fr) | Nouveau procédé d'obtention de substances vaso-actives extraites de feuilles de ginkgo | |
| WO1995004592A1 (fr) | Compositions aqueuses concentrees d'alkylpolyglycosides et leurs utilisations | |
| BE438175A (en, 2012) | ||
| EP0482344B1 (fr) | Procédé d'obtention de composés insaponifiables | |
| EP3750873B1 (fr) | Procédé de fabrication de n-acétyl-taurinate de magnésium | |
| EP0069674B1 (fr) | Médicaments contenant une N-acyl-L-aspartyl-taurine | |
| EP0092287B1 (fr) | Sels d'acétylcystéine, leur préparation et leur utilisation | |
| CA1154555A (fr) | Bactericide | |
| FR2475546A1 (fr) | Phenoxyisobutyrates de moroxydine et medicaments les contenant | |
| CH406194A (fr) | Procédé de préparation de sels stables de diméthylcarboxy-alkylsulfonium | |
| EP0409703B1 (fr) | Préparation pour la décontamination et le nettoyage des lentilles de contact, et son utilisation | |
| BE346530A (en, 2012) | ||
| BE520828A (en, 2012) | ||
| LU84421A1 (fr) | Sels d'acide ursodesoxycholique,leur preparation et leur utilisation | |
| BE530825A (en, 2012) | ||
| BE332653A (en, 2012) | ||
| CH396027A (fr) | Procédé de dédoublement de la DL-lysine | |
| CH376931A (fr) | Procédé de fabrication de sels d'oxytocine | |
| BE402029A (en, 2012) |